Skip to main content
FinSpry Logo
FinSpry
LPCN logo
LPCN
(NASDAQ)
Lipocine Inc.
$2.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lipocine (LPCN) Stock Price & Financial Analysis

Lipocine Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.21 - $2.28
52-Week High$12.37
52-Week Low$1.81
Open$2.26
Volume85.95K
Average Volume (3M)386.02K
Market Cap12.90M
Shares Outstanding5.71M
Price to Sales (P/S)6.53
Price to Book (P/B)0.89
EV/EBITDA-0.75
Revenue (TTM)1.98M
Net Income (TTM)-9.63M
Free Cash Flow (TTM)-9.76M
EPS (TTM)$-1.76
Profit Margin-487.06%
Operating Margin-524.69%
Return on Equity (ROE)-66.50%
Debt to Equity0.00
50-Day MA$4.73
200-Day MA$4.79
52-Week Change-20.55%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lipocine

What is the current stock price for LPCN?

As of the latest trading session, LPCN stock trades at $2.21. The 52-week range is $1.81–$12.37, with a day range of $2.21–$2.27.

What is the P/E ratio for LPCN?

The P/E ratio (Price-to-Earnings) for LPCN is shown in the Key Statistics section. This valuation metric helps compare Lipocine Inc. to industry peers.

Does LPCN pay dividends?

Lipocine does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LPCN?

Based on 1 analyst, the consensus for LPCN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LPCN?

Lipocine's market capitalization is $12.6M, classifying it as a micro-cap company. Lipocine operates in the Healthcare sector within the Biotechnology industry.